Clinical Trials Browser

Completed × Osteosarcoma × Sirolimus × Clear all

NCT02517918 2025-06-08

METZOLIMOS

Phase 1 Completed

23 enrolled 15 charts

Osteosarcoma

NCT01331135 2020-05-29

Aflac ST0901

Phase 1 Completed

CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Astrocytoma, Carcinoma, Renal Cell, Ependymoma, Glioma, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Recurrence, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Sarcoma, Clear Cell, Rhabdoid Tumor

NCT01614795 2018-12-11

Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma

Phase 2 Completed

46 enrolled 13 charts

Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00743509 2015-09-28

OCR

Phase 2 Completed

49 enrolled 7 charts

Neoplasm Metastasis, Recurrence, Sarcoma, Osteosarcoma

NCT01016015 2015-07-30

Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma

Phase 2 Completed

178 enrolled 6 charts

Sarcoma, Osteosarcoma

NCT02429973 2015-04-29

GEIS-29

Phase 2 Completed

Osteosarcoma